归创通桥医疗科技股份有限公司(02190)于2026年3月24日公告，当日于香港联交所场内回购股份2.85万股，占当日已发行股本约0.0085%，每股回购价介乎港币22.86元至23.50元，总计耗资约66.56万港元。回购后，公司已发行股本由329,253,613股降至329,225,113股，库藏股数则增至7,125,631股。
根据公告，公司取得的回购授权通过日期为2025年5月30日，可回购股份总数为31,958,111股，此前已累计回购4,306,000股。本次操作遵守香港联交所相关上市规则及 applicable 法律规定。
公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.